This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.
Ocrevus is a CD20-directed cytolytic antibody indicated for the treatment of:
Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Primary progressive MS, in adults.
In case of any adverse events or safety queries, please contact:
If you have a scientific query related to one of Roche's products, please contact:
M-PK-00001707
Solutions